These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22920015)

  • 21. Principles of Therapeutic Apheresis in Neurological Disease.
    Strasser E
    Transfus Med Hemother; 2023 Apr; 50(2):88-97. PubMed ID: 37066058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmapheresis in neurological disorders: six years experience from University Clinical center Tuzla.
    Sinanović O; Zukić S; Burina A; Pirić N; Hodžić R; Atić M; Alečković-Halilović M; Mešić E
    F1000Res; 2017; 6():1234. PubMed ID: 28928949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
    Prytuła A; Vande Walle J; Verhelst H; Eloot S; Claus S; De Jaeger A; Dehoorne J; Raes A
    Int J Artif Organs; 2015 Sep; 38(9):494-500. PubMed ID: 26449568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The top clinical trial opportunities in therapeutic apheresis and neurology.
    Morgan SM; Shaz BH; Pavenski K; Meyer EK; Delaney M; Szczepiorkowski ZM
    J Clin Apher; 2014 Dec; 29(6):331-5. PubMed ID: 24899381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Pham HP; Schwartz J
    Presse Med; 2019 Nov; 48(11 Pt 2):338-346. PubMed ID: 31679897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasmapheresis in central nervous system disorders].
    Antozzi C
    G Ital Nefrol; 2012; 29 Suppl 54():S130-4. PubMed ID: 22388844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre.
    Das J; Chauhan VD; Mills D; Johal NJ; Tan M; Matthews R; Keh R; Lilleker JB; Gosal D; Sharaf N
    Transfus Apher Sci; 2019 Dec; 58(6):102654. PubMed ID: 31648858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urgent therapeutic plasma exchange.
    Saheb S; Gallo A
    Transfus Apher Sci; 2020 Dec; 59(6):102991. PubMed ID: 33221122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmapheresis for neurological disorders.
    Schröder A; Linker RA; Gold R
    Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic plasma exchange in clinical pediatric neurology practice: Experience from a tertiary referral hospital.
    Yıldırım M; Bektaş Ö; Botan E; Şahin S; Gurbanov A; Teber S; Kendirli T
    Clin Neurol Neurosurg; 2021 Aug; 207():106823. PubMed ID: 34304066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic plasma exchange: applications in neurology].
    Láinez-Andrés JM; Gascón-Giménez F; Coret-Ferrer F; Casanova-Estruch B; Santonja JM
    Rev Neurol; 2015 Feb; 60(3):120-31. PubMed ID: 25624088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory therapies in neurologic critical care.
    McDaneld LM; Fields JD; Bourdette DN; Bhardwaj A
    Neurocrit Care; 2010 Feb; 12(1):132-43. PubMed ID: 19774497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2009 Dec; 10(5):129-32. PubMed ID: 20129391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review: the use of rituximab in neuromuscular diseases.
    Ibrahim H; Dimachkie MM; Shaibani A
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):91-102. PubMed ID: 21386778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic Apheresis in Neurological Disorders].
    Nakatsuji Y
    Brain Nerve; 2021 May; 73(5):425-430. PubMed ID: 34006672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoadsorption in neurological disorders.
    Oji S; Nomura K
    Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.